We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-35.01%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$152M
AUM Growth
-$121M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$87.7M 57.68%
19,363,975
RVMD icon
2
Revolution Medicines
RVMD
$39.9B
$27.7M 18.2%
1,419,900
PLRX icon
3
Pliant Therapeutics
PLRX
$64.4M
$17.1M 11.23%
2,132,867
FULC icon
4
Fulcrum Therapeutics
FULC
$273M
$11.5M 7.55%
2,343,154
DNTH icon
5
Dianthus Therapeutics
DNTH
$5.84B
$8.11M 5.33%
422,388

Similar funds

TRV GP IV's Q2 2022 Portfolio in Review

As of Q2 2022, TRV GP IV held 5 positions worth $152M, down 44% from $273M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $152M portfolio in Q2 2022.
  • TRV GP IV opened 0 new positions and closed 0 in Q2 2022.
  • TRV GP IV's portfolio value fell 44% quarter-over-quarter to $152M.

Based on TRV GP IV's 13F filing for Q2 2022, filed 12 Aug 2022.